SGN-75 is an ADC comprising an anti-CD70 antibody linked to a potent, synthetic drug payload, monomethyl auristatin F , using a proprietary technology from Seattle Genetics. The product is designed to be stable in blood, but to deliver his load on internalization into tumor cells that express CD70, thus killing the target cells. Continue reading
-
Recent Posts
- All about Tamsulosin Hydrochloride
- The White House has called the initiative to develop Global Health
- Predict the outcome of pregnancies threaten to abort
- Change “grain of high fructose corn syrup”, “corn sugar” called, the application of Industry Regulation
- Anti-Anxiety: Generic Celexa (Citalopram)
Recent Comments
Archives
Categories
Meta